Fungal Keratinases: Enzymes with Immense Biotechnological Potential

Bhari, Ranjeeta; Kaur, Manpreet

doi:10.1007/978-981-19-9103-5_4

Cited by 2 publications

(1 citation statement)

References 136 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…T. rubrum is the most common species of Trichophyton isolated from human skin, followed by T. mentagrophytes . This was proven abundantly evident in Europe, where a high rate of T. rubrum infection was documented, but in Asia, a greater incidence of T. mentagrophytes was seen . The conditions of dermatophytosis vary greatly from region to region and even within the same country.…”

Section: Epidemiology Of Dermatophytosis Geographicallymentioning

confidence: 99%

Superficial Dermatophytosis across the World’s Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges

Keshwania,

Kaur,

Chauhan

et al. 2023

ACS Omega

View full text Add to dashboard Cite

The most prevalent infection in the world is dermatophytosis, which is a major issue with high recurrence and can affect the entire body including the skin, hair, and nails. The major goal of this Review is to acquire knowledge about cutting-edge approaches for treating dermatophytosis efficiently by adding antifungals to formulations based on nanocarriers in order to overcome the shortcomings of standard treatment methods. Updates on nanosystems and research developments on animal and clinical investigations are also presented. Along with the currently licensed formulations, the investigation also emphasizes novel therapies and existing therapeutic alternatives that can be used to control dermatophytosis. The Review also summarizes recent developments on the prevalence, management approaches, and disadvantages of standard dosage types. There are a number of therapeutic strategies for the treatment of dermatophytosis that have good clinical cure rates but also drawbacks such as antifungal drug resistance and unfavorable side effects. To improve therapeutic activity and get around the drawbacks of the traditional therapy approaches for dermatophytosis, efforts have been described in recent years to combine several antifungal drugs into new carriers. These formulations have been successful in providing improved antifungal activity, longer drug retention, improved effectiveness, higher skin penetration, and sustained drug release.

show abstract

Section: Epidemiology Of Dermatophytosis Geographicallymentioning

confidence: 99%